New York’s adult-use marijuana industry is poised to significantly expand after state regulators on Tuesday voted to begin issuing more business licenses next month.
Regulators previously issued dispensary licenses exclusively to business owners impacted by prior marijuana-related convictions. That policy stemmed, in part, from the state’s 2021 marijuana law that included requirements to make amends for biased enforcement of past cannabis prohibition.
But the restrictive licensing process has resulted in just 23 dispensaries opening statewide so far. At the same time, black-market drug dealers undermined the legal marketplace and lawsuits challenged the constitutionality of excluding other dispensary applicants.
Now, the state Office of Cannabis Management’s general license application rollout will begin on Oct. 4, allowing all marijuana businesses to apply for cultivator, processor, distributor, microbusiness, and retail dispensary licenses.
How ‘big cannabis’ benefits from NY expansion
Several measures approved Tuesday stand out for allowing some of the largest national cannabis corporations to expand their operations in New York.
For example, the 10 currently licensed medical marijuana businesses in New York will be allowed to pay a one-time special licensing fee of $20 million to start operating adult-use businesses here. Most of these companies have links to marijuana industries in several states across the country.
NY marijuana court battle: New York judge halts most new marijuana dispensary licenses. What to know
Paying that fee — which includes a $5 million initial investment followed by installments tied to hitting various benchmarks — will provide those 10 companies with a head start to exclusively operate potentially lucrative seed-to-sale operations in New York, with caveats about financial ownership.
In contrast, other businesses on the supply side of the marijuana market — but which lack a medical cannabis license and other related requirements — are prohibited from having more than a minimal financial interest in businesses on the retail side of the market, the regulations show.
The Cannabis Association of New York, a marijuana industry trade group, noted Tuesday’s vote “opened the door for big cannabis to come in and compete with New York-based businesses.”
But “to protect locally-based small businesses,” regulators must consider other reforms such as revising the marijuana potency tax and limits on canopy space for growers, the trade group said in a statement, adding the recent state-led crack down on illegal marijuana shops must remain a priority.
The 23 adult-use dispensaries currently open statewide have reported a total of about $70 million in sales through late August, regulators said Tuesday. That tally marked a big jump from earlier in the year, but remains far from realizing the lofty political promises of state lawmakers who championed the 2021 marijuana law.
How cannabis lobbying unfolded in NY
Many of those 10 current medical marijuana companies have also spent millions of dollars lobbying lawmakers and regulators in New York since the state legalized medical marijuana in 2014.
Some of that lobbying, as well as related campaign donations to key politicians, aimed at forging a pathway from medical use into the adult-use marketplace. The push prompted some anti-marijuana advocates to describe medical marijuana as a Trojan horse for legalization of so-called recreational use of the drug.
Marijuana politics: Marijuana legalization in New York: Here’s the money behind politically charged pot war
Now, some of the medical marijuana companies have invested millions of dollars to build massive cannabis grow operations, including several in the Hudson Valley, in hopes of landing an adult-use cultivator license.
These medical marijuana companies will also be allowed to sell adult-use marijuana at up to three medical cannabis dispensaries, the regulations show.
How do NY marijuana lawsuits impact expansion?
The industry expansion vote came after a judge last month issued an order temporarily blocking New York from issuing new marijuana dispensary licenses.
At the time, Justice Kevin Bryant allowed businesses currently operating marijuana dispensaries to remain open. He also ruled that Conditional Adult-Use Retail Dispensary (CAURD) applicants that met all requirements for licensing by Aug. 7 could keep moving forward to open their dispensaries.
But in a new ruling on Monday, Bryant rescinded the exclusion for CAURD applicants, asserting regulators failed to provide sufficient documentation and details to show the applicants met the Aug. 7 cutoff.
Bryant has also ordered New York to hit its deadline for opening general applications next month, saying that could resolve many of the issues in the court battle.
What’s next for NY’s small business cannabis retailers?
Still, the judge’s rulings and comments in court have cast doubt on the future of businesses currently operating on CAURD licenses, as well as those that asserted they met the Aug. 7 cutoff, only to have that exclusion removed.
“It is certainly conceivable that a successful challenge to the CAURD program could result in a finding that the licenses are invalid,” Bryant wrote in one ruling.
In other words, the court battle could force CAURD businesses to start the application process over just as the industry opens to deep-pocketed competitors.
Meanwhile, some of those CAURD business hopefuls include former convicts who say they invested life savings to secure a legal marijuana dispensary license and retail space, only to have the court fight endanger their small-business dreams just days from opening.
This article originally appeared on Rockland/Westchester Journal News: NY marijuana: General retail licenses coming soon. What to know
Recent Comments